Description
Additional file 1: Supplementary Table 1. List of drugs used in the study, Supplementary Table 2. List of primers used in this study.
| Dati resi disponibili | 2024 |
|---|---|
| Editore | figshare |
Additional file 1 of Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer
- Chiara Naro (Creatore)
- Ambra Antonioni (Creatore)
- Vanessa Medici (Creatore)
- Cinzia Caggiano (Creatore)
- Ariane Jolly (Creatore)
- Pierre de la Grange (Creatore)
- Pamela Bielli (Creatore)
- Maria Paola Paronetto (Creatore)
- Claudio Sette (Creatore)
Dataset